Table 1. Baseline characteristics of participants.
| Characteristics | Variables (n = 91) |
|---|---|
| Age, yr | 56.03 ± 10.80 |
| Sex, male/female (%) | 35 (38.5)/56 (61.5) |
| BMI, kg/m2 | 23.67 ± 3.58 |
| DM duration, yr | 7.09 ± 6.11 |
| SBP, mmHg | 126.78 ± 13.33 |
| DBP, mmHg | 78.92 ± 8.42 |
| HbA1c, % | 7.62 ± 1.61 |
| HbA1c, mmol/mol | 59.8 ± 17.5 |
| eGFR, mL/min/1.73m2 | 90.79 ± 15.26 |
| Total cholesterol, mg/dL | 178.92 ± 38.98 |
| LDL cholesterol, mg/dL | 105.63 ± 34.57 |
| HDL cholesterol, mg/dL | 49.57 ± 13.41 |
| Triglyceride, mg/dL | 142.5 (94.0–204.5) |
| CRP, mg/dL | 0.05 (0.03–0.13) |
| Urine ACR, mg/g Cr | 23.45 (8.73–87.55) |
| Urine AGT/Cr, µg/g Cr | 12.48 (6.74–31.39) |
| Lipid lowering agent, No. (%) | 49 (53.8) |
| Diabetic reinopathy, No. (%) | 31 (34.1) |
Data are expressed as mean ± SD and median (IQR) for continuous variables and frequencies (%) for categorical variables.
BMI = body mass index, DM = diabetes mellitus, SBP = systolic blood pressure, DBP = diastolic blood pressure, HbA1c = hemoglobin A1c, eGFR = estimated glomerular filtration rate, LDL = low-density lipoprotein, HDL = high-density lipoprotein, CRP = C-reactive protein, ACR = albumin-to-creatinine ratio, AGT = angiotensinogen, Cr = creatinine, SD = standard deviation, IQR = interquartile range.